Amicus Therapeutics’ (FOLD) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $21.
bovnews17h
What’s Fueling Amicus Therapeutics, Inc. (FOLD) Stock’s -9.87% Loss Below Its 200-Day SMA?
Amicus Therapeutics, Inc. (FOLD) stock saw a modest uptick, ending the day at $9.41 which represents a slight increase of $0.05 or 0.53% from the prior close of $9.36. The stock opened at $9.46 and ...